JP2004516234A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004516234A5 JP2004516234A5 JP2001579743A JP2001579743A JP2004516234A5 JP 2004516234 A5 JP2004516234 A5 JP 2004516234A5 JP 2001579743 A JP2001579743 A JP 2001579743A JP 2001579743 A JP2001579743 A JP 2001579743A JP 2004516234 A5 JP2004516234 A5 JP 2004516234A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20156700P | 2000-05-01 | 2000-05-01 | |
| US70233200A | 2000-10-31 | 2000-10-31 | |
| PCT/US2001/013988 WO2001082867A2 (en) | 2000-05-01 | 2001-05-01 | A core formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004516234A JP2004516234A (ja) | 2004-06-03 |
| JP2004516234A5 true JP2004516234A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
Family
ID=26896877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001579743A Pending JP2004516234A (ja) | 2000-05-01 | 2001-05-01 | コア製剤 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1278513B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004516234A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE367151T1 (cg-RX-API-DMAC7.html) |
| AU (2) | AU5745601A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2407713A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60129425T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2290130T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001082867A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN192749B (cg-RX-API-DMAC7.html) * | 2002-11-15 | 2004-05-15 | Ranbaxy Lab Ltd | |
| AR045330A1 (es) * | 2003-08-07 | 2005-10-26 | Sb Pharmco Inc | Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla |
| GB0318824D0 (en) * | 2003-08-11 | 2003-09-10 | Glaxo Group Ltd | Novel composition |
| EP1841414A1 (en) * | 2003-12-31 | 2007-10-10 | Alpharma, Inc. | Rosiglitazone and metformin formulations |
| US20050163837A1 (en) * | 2003-12-31 | 2005-07-28 | Garth Boehm | Rosiglitazone formulations |
| FR2896159B1 (fr) | 2006-01-13 | 2008-09-12 | Merck Sante Soc Par Actions Si | Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline. |
| RU2567032C2 (ru) * | 2009-05-01 | 2015-10-27 | Апталис Фарматек, Инк. | Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166800A (en) * | 1977-08-25 | 1979-09-04 | Sandoz, Inc. | Processes for preparation of microspheres |
| ES2052369T3 (es) * | 1990-01-30 | 1994-07-01 | Akzo Nv | Articulo para el suministro controlado de una sustancia activa, que comprende un espacio hueco completamente cerrado por una pared y lleno en su totalidad o en parte con una o mas sustancias activas. |
| AUPM897594A0 (en) * | 1994-10-25 | 1994-11-17 | Daratech Pty Ltd | Controlled release container |
| US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
| TR199903057T2 (xx) * | 1997-06-18 | 2000-04-21 | Smithkline Beecham Plc | Diabetin tiazolidinedion ve metformin ile tedavisi. |
| US6099862A (en) * | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
| JP2003514011A (ja) * | 1999-11-16 | 2003-04-15 | スミスクライン ビーチャム パブリック リミテッド カンパニー | チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物 |
| MY125516A (en) * | 1999-11-16 | 2006-08-30 | Smithkline Beecham Plc | Novel composition based on thiazolidinedione and metformin and use |
-
2001
- 2001-05-01 AU AU5745601A patent/AU5745601A/xx active Pending
- 2001-05-01 ES ES01930970T patent/ES2290130T3/es not_active Expired - Lifetime
- 2001-05-01 AU AU2001257456A patent/AU2001257456B2/en not_active Ceased
- 2001-05-01 JP JP2001579743A patent/JP2004516234A/ja active Pending
- 2001-05-01 AT AT01930970T patent/ATE367151T1/de not_active IP Right Cessation
- 2001-05-01 EP EP01930970A patent/EP1278513B1/en not_active Expired - Lifetime
- 2001-05-01 WO PCT/US2001/013988 patent/WO2001082867A2/en not_active Ceased
- 2001-05-01 CA CA002407713A patent/CA2407713A1/en not_active Abandoned
- 2001-05-01 DE DE60129425T patent/DE60129425T2/de not_active Expired - Fee Related